Pharma Journalist -

Dova Pharmaceutical and Salix Pharmaceuticals announced that they have entered into an exclusive agreement to co-promote Dova’s DOPTELET (avatrombopag) in the United States (U.S.). The…
Read More...

SMi Reports: An exclusive interview with Anita Burrell, Founder & CEO at Anita Burrell Consulting and speaker at this year’s 5th annual Biosimilars USA conference, is now available…
Read More...

Selexis SA and Hoba Therapeutics announced that they have entered into an agreement to advance the development of Hoba’s clinical candidate HB-086 (rhMeteorin) for the treatment of…
Read More...

Alexion Pharmaceuticals and Syntimmune announced that they have entered into a definitive agreement for Alexion to acquire Syntimmune, a clinical-stage biotechnology company developing…
Read More...

SMi Group announces the 10th Annual RNA Therapeutics Conference in London on February 20th - 21st 2019. Undoubtedly, the field of RNA therapeutics is currently undergoing a major…
Read More...

SMi is excited to present the return of their 11th annual Social Media in the Pharmaceutical Industry conference to London, UK on the 21st - 22nd January 2019! This year looks at…
Read More...

The Future of Drug Delivery & Combination products SMi is proud to present their 11th leading annual european conference and exhibition, within the Pre-Filled Syringes series:…
Read More...

AstraZeneca announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion on a Type-II variation update…
Read More...

Myelo Therapeutics GmbH announced that the US Food and Drug Administration (FDA) has granted an Orphan Drug Designation to its orally applied new chemical entity Myelo001 for the…
Read More...

Infor announced that Ibnsina Pharma has invested in Infor EAM, Infor d/EPM, Infor M3, Infor SCE (Warehouse Management System), and Infor OS to help unify and integrate its business…
Read More...